Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report
J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report
J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report
Submitted by
admin
on January 25, 2022 - 11:41pm
Source:
CNBC
News Tags:
JNJ
earnings
vaccines
COVID-19
Headline:
J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report
snippet:
J&J expects its Covid vaccine to generate $3 billion to $3.5 billion in sales this year.
The company beat on fourth-quarter earnings but missed on revenue.
Its revenue of $24.8 billion rose 10.4% over the same quarter in 2020, mostly driven by $1.82 billion in international sales of its Covid vaccine.
Do Not Allow Advertisers to Use My Personal information
